Objective: Previous research conducted by the Blue Cross Blue Shield of Michigan Center for Health Care Quality and Evaluative Studies revealed that plan members diagnosed with conditions that usually have a viral etiology (colds, upper respiratory tract infections, and bronchitis) received antibiotics at high rates. Based upon these findings, a concern was raised that similar behavior may be taking place for another common viral infection – influenza. The objective of this report is to describe the use of antibiotics by patients with influenza. Methods: Data for this study were extracted from BCBSM professional, drug, and outpatient facility paid claims, and membership files. Patients were selected if they were Michigan residents; non-Medicare BCBSM members; under the age of 65; with professional, facility, and drug coverage. Patients could be enrolled in the Indemnity, PPO, or (POS) program. Patients had to receive a service billed with a diagnosis of influenza. Patients were excluded if they had comorbidities of pneumonia, emphysema, asthma, or COPD. Results: Data are currently being analyzed to determine the rate of antibiotic use. Preliminary results suggest that patients with influenza received antibiotics about half as often as those who received antibiotics for acute respiratory (viral) infections. Conclusion: The use of antibiotics for viral infections is generally not beneficial for either patients or society. Patients with influenza are about half as likely as those with colds and URIs to receive antibiotics.
Learning Objectives: Attendees will be able to describe the extent to which antibiotics are used inappropriately for the treatment of influenza and how this impacts the development of antibiotic resistance. Attendees will be able to identify interventions designed to promote the appropriate use of antibiotics.
Keywords: Antibiotic Resistance, Infectious Diseases
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: This research was conducted by Blue Cross Blue Shield of Michigan using proprietary data.
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.